![]() | ARTICLE ABSTRACT | |||||||
| DOI: 10.1099/vir.0.19110-0 | ||||||||
| Online 22 April 2003 | ||||||||
Judie B. Alimonti, T. Blake Ball and Keith R. Fowke
Department of Medical Microbiology and Infectious
Diseases, University of Manitoba, 539-730 William Avenue, Winnipeg,
MB, Canada R3E 0W3
AIDS, caused by the retroviruses human
immunodeficiency virus type 1 and type 2 (HIV-1 and HIV-2), has
reached pandemic proportions. Therefore, it is critical to
understand how HIV causes AIDS so that appropriate therapies can be
formulated. Primarily, HIV infects and kills CD4+ T lymphocytes,
which function as regulators and amplifiers of the immune response.
In the absence of effective anti-retroviral therapy, the hallmark
decrease in CD4+ T lymphocytes during AIDS results in a weakened
immune system, impairing the body's ability to fight
infections or certain cancers such that death eventually ensues.
The major mechanism for CD4+ T cell depletion is programmed cell
death (apoptosis), which can be induced by HIV through multiple
pathways. Death of HIV-infected cells can result from the
propensity of infected lymphocytes to form short-lived syncytia or
from an increased susceptibility of the cells to death. However,
the apoptotic cells appear to be primarily uninfected bystander
cells and are eradicated by two different mechanisms: either a
Fas-mediated mechanism during activation-induced cell death (AICD),
or as a result of HIV proteins (Tat, gp120, Nef, Vpu) released from
infected cells stimulating apoptosis in uninfected bystander cells.
There is also evidence that as AIDS progresses cytokine
dysregulation occurs, and the overproduction of type-2 cytokines
(IL-4, IL-10) increases susceptibility to AICD whereas type-1
cytokines (IL-12, IFN-
) may be protective. Clearly there are
multiple causes of CD4+ T lymphocyte apoptosis in AIDS and
therapies that block or decrease that death could have significant
clinical benefit.
© 2003 SGM
This article is now available in the July 2003 print issue of JGV (vol. 84, 16491661). The complete issue of the journal may be seen in electronic form on JGV Online.